Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 117 | 119 | PF00675 | 0.549 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.669 |
CLV_NRD_NRD_1 | 65 | 67 | PF00675 | 0.605 |
CLV_NRD_NRD_1 | 91 | 93 | PF00675 | 0.591 |
CLV_PCSK_KEX2_1 | 117 | 119 | PF00082 | 0.549 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.490 |
CLV_PCSK_KEX2_1 | 21 | 23 | PF00082 | 0.566 |
CLV_PCSK_KEX2_1 | 65 | 67 | PF00082 | 0.605 |
CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.610 |
CLV_PCSK_PC1ET2_1 | 21 | 23 | PF00082 | 0.637 |
CLV_PCSK_PC7_1 | 133 | 139 | PF00082 | 0.671 |
CLV_PCSK_PC7_1 | 87 | 93 | PF00082 | 0.626 |
CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.708 |
CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.592 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.467 |
DEG_SPOP_SBC_1 | 100 | 104 | PF00917 | 0.557 |
DOC_MAPK_JIP1_4 | 7 | 13 | PF00069 | 0.513 |
DOC_USP7_MATH_1 | 128 | 132 | PF00917 | 0.728 |
DOC_USP7_MATH_1 | 67 | 71 | PF00917 | 0.662 |
DOC_WW_Pin1_4 | 171 | 176 | PF00397 | 0.601 |
LIG_14-3-3_CanoR_1 | 155 | 161 | PF00244 | 0.556 |
LIG_14-3-3_CanoR_1 | 66 | 72 | PF00244 | 0.695 |
LIG_CtBP_PxDLS_1 | 151 | 155 | PF00389 | 0.368 |
LIG_FHA_1 | 163 | 169 | PF00498 | 0.591 |
LIG_LIR_Gen_1 | 162 | 172 | PF02991 | 0.674 |
LIG_LIR_Nem_3 | 162 | 167 | PF02991 | 0.638 |
LIG_SH2_CRK | 164 | 168 | PF00017 | 0.654 |
LIG_SH2_STAP1 | 164 | 168 | PF00017 | 0.522 |
LIG_SH2_STAT5 | 164 | 167 | PF00017 | 0.637 |
LIG_SH2_STAT5 | 40 | 43 | PF00017 | 0.542 |
LIG_SH3_3 | 169 | 175 | PF00018 | 0.572 |
MOD_CK1_1 | 159 | 165 | PF00069 | 0.539 |
MOD_CK1_1 | 174 | 180 | PF00069 | 0.621 |
MOD_CK1_1 | 42 | 48 | PF00069 | 0.672 |
MOD_GlcNHglycan | 41 | 44 | PF01048 | 0.586 |
MOD_GlcNHglycan | 79 | 82 | PF01048 | 0.599 |
MOD_GlcNHglycan | 8 | 11 | PF01048 | 0.510 |
MOD_GSK3_1 | 162 | 169 | PF00069 | 0.564 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.547 |
MOD_N-GLC_1 | 162 | 167 | PF02516 | 0.608 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.539 |
MOD_NEK2_1 | 156 | 161 | PF00069 | 0.528 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.572 |
MOD_NEK2_2 | 14 | 19 | PF00069 | 0.555 |
MOD_PIKK_1 | 128 | 134 | PF00454 | 0.732 |
MOD_PIKK_1 | 162 | 168 | PF00454 | 0.637 |
MOD_PIKK_1 | 65 | 71 | PF00454 | 0.601 |
MOD_PKA_1 | 21 | 27 | PF00069 | 0.542 |
MOD_PKA_1 | 65 | 71 | PF00069 | 0.601 |
MOD_PKA_2 | 21 | 27 | PF00069 | 0.504 |
MOD_PKA_2 | 58 | 64 | PF00069 | 0.552 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.606 |
MOD_PKA_2 | 65 | 71 | PF00069 | 0.611 |
MOD_Plk_1 | 162 | 168 | PF00069 | 0.619 |
MOD_ProDKin_1 | 171 | 177 | PF00069 | 0.599 |
TRG_ENDOCYTIC_2 | 164 | 167 | PF00928 | 0.672 |
TRG_ENDOCYTIC_2 | 50 | 53 | PF00928 | 0.535 |
TRG_ER_diArg_1 | 116 | 118 | PF00400 | 0.552 |
TRG_ER_diArg_1 | 136 | 138 | PF00400 | 0.407 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I402 | Leptomonas seymouri | 81% | 100% |
A0A0S4JQA3 | Bodo saltans | 57% | 100% |
A0A1X0P2R8 | Trypanosomatidae | 65% | 100% |
A0A3Q8IJU1 | Leishmania donovani | 91% | 100% |
A0A422NYD9 | Trypanosoma rangeli | 70% | 95% |
A4HL44 | Leishmania braziliensis | 92% | 100% |
C9ZPU8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 66% | 94% |
E9AHM6 | Leishmania infantum | 91% | 100% |
Q4Q4L5 | Leishmania major | 96% | 100% |
V5DB04 | Trypanosoma cruzi | 70% | 83% |